Diabetes Information [Return To Home Page]

Benfotiamine - A New Tool In Preventing Diabetic Complications?


Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:

The Guardian

Diabetes in pregnancy ups birth defects risk
Times of India
Diabetes during pregnancy increases the risk of birth defects, such as congenital heart disease and spina bifida, by four-fold, researchers say. National guidelines already recommend having good control over blood sugar levels before trying to conceive ...
Diabetes quadruples birth defects risk, say researchersBBC News
Diabetes 'raises birth defect risk'The Press Association
Women with diabetes warned to take precautions when having a babyThe Guardian
Daily Mail
all 209 news articles »


Take steps to detect, reverse pre-diabetes
Wisconsin Rapids Tribune
Pre-diabetes is a condition in which a person's blood sugar is elevated but not high enough to be classified as type 2 diabetes. It's a very important condition to understand because there are so many people who, if they realized they had pre-diabetes, ...
The Diabetic Week in Review -- Week Ending 4 February 2012Examiner.com

all 2 news articles »


TopNews United States

Diabetes: Celebrating The Silent Killer
Leadership Newspapers
With the worsening incidence of diabetes sweepiing across the world, EZRA IJIOMA examines the different types of diabetes and reasons for its high incidence in Nigeria. In 2003, when he was 21 years old, Ken developed a puzzling, unquenchable thirst.
A Stomach Bug and DiabetesdailyRx
Diabetes is his daily challengeBlacktown Sun
Former office manager, a diabetic, sues Casper company for discriminationCasper Star-Tribune Online
MLB.com -The Cypress Times -TopNews United States
all 11 news articles »


Research and Markets: Brazil Diabetes Care Devices Market Outlook to 2017 ...
SunHerald.com
GlobalData's new report, Brazil Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the Brazil Diabetes Care Devices market. The report provides value (USD million), volume (units) and ...

and more »


Medical experts meet in S'pore for diabetes workshop
Channel News Asia
SINGAPORE: Leading international experts in type 2 diabetes are in Singapore to address specific challenges and opportunities of bariatric or metabolic surgery for Asian patients and health care systems. The Asia-Pacific Workshop on Metabolic Surgery ...

and more »


PR Web (press release)

Diabetes is One of the Fastest Deadly Growing Diseases around the World
PR Web (press release)
According to the Centers for Disease Control in the USA: Diabetes is an epidemic. 17 million Americans have diabetes with 5.9 million completely unaware that they even have the disease. Diabetes is the 5th leading cause of death in the United States ...



Diabetes amputations drop, but disease expands
SouthCoastToday.com
By ANIKA CLARK The Centers for Disease Control and Prevention published good news recently for the nation's diabetic adults. In 2008, substantially fewer of them 40 and older received lower limb amputations than they had 12 years prior.



US Drug Watchdog Expands Their Initiative for Diabetics Who Used the Diabetes ...
San Francisco Chronicle (press release)
The US Drug Watchdog says, "We totally underestimated the number of diabetics in the United States, who used the diabetes drug called Actos, and now have bladder cancer. We now believe the number of diabetics, who used the diabetes drug called Actos, ...



The Curse of Amylin's Diabetes Drug Approval
TheStreet.com
... after more than two and a half years, two FDA rejection letters, and at least a dozen amendments to the application, Amylin Pharmaceuticals(AMLN) received FDA approval for Bydureon, a once-weekly formulation of its existing diabetes drug Byetta.



Sports-themed windows to benefit diabetes research
Muncie Star Press
MUNCIE -- Pat L. Smith, owner of build, LLC, is offering a collection of sports-themed windows and doors to raise funds for the Juvenile Diabetes Research Foundation. Smith's son, Eric, was diagnosed as a Type 1 diabetic at the age of 23 while serving ...


Google News






home | site map
© 2006